gliclazide has been researched along with Drug Associated Myopathies in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, KF | 1 |
| Mak, MWH | 1 |
| Lao, VWN | 1 |
| Yip, HLK | 1 |
| Lau, WY | 1 |
| Wong, VTL | 1 |
1 other study available for gliclazide and Drug Associated Myopathies
| Article | Year |
|---|---|
Immune-mediated necrotising myopathy is a rare statin-associated adverse effect: a case report.
Topics: Atorvastatin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyslipidemias; Female; Gliclazid | 2020 |